GlassScriptPhysician profile
George L King
NPI 1669458816
$23,876.56
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $4,275 · 2021: $2,700 · 2022: $4,050.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $12,751.56 | 2019 | |
| Medtronic, INC. | $6,750.00 | 2021-2022 | |
| Medtronic Minimed, INC. | $3,150.00 | 2020 | |
| Agios Pharmaceuticals, INC. | $1,125.00 | 2020 | |
| Novo Nordisk US Research & Development, INC. | $100.00 | 2019 |
3 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.